Medical Oncology

Dr. Bayarmaa Khishigsuren

Doctor and researcher Acıbadem Altunizade Hastanesi İstanbul
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: acibadem.com.tr.

  • Meme Kanseri

CV

Education and experience

From source

Experience

  • 2015Acıbadem Sağlık Grubuacibadem.com.tr
  • 2015 - 2021Özel Kadıköy Florence Nightingale Hastanesi - Uzman Hekimacibadem.com.tr

Education

  • 2025İstanbul Üniversitesi İstanbul Tıp Fakültesi, Tıbbi Onkoloji, Üst Uzmanlıkacibadem.com.tr
  • 2015İstanbul Üniversitesi İstanbul Tıp Fakültesi, İç Hastalıkları, Uzmanlıkacibadem.com.tr
  • 2010Uludağ Üniversitesi Tıp Fakültesi, Üniversiteacibadem.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologyacibadem.com.trFrom source
  • InstitutionAcıbadem Altunizade Hastanesiacibadem.com.trFrom source
  • Publications7 publicationsOpenAlex, ORCIDFrom source
  • ORCID0009-0004-9455-6962ORCIDFrom source
  • Last synchronised4 November 2026 21:14https://www.acibadem.com.tr/doktor/bayarmaa-khishigsuren/acibadem.com.tr

Scientific work

Publications

7 publications

  1. The efficacy of second-line chemotherapy in the management of classic and iatrogenic Kaposi sarcoma: An analysis of real-world data

    Medicine, 2025

    DOI 10.1097/md.0000000000041404 PMID 39928795 Open-access full textSource: OpenAlex

  2. Rechallenge of trastuzumab-based therapy in HER2-positive breast cancer patients who progressed after lapatinib plus capecitabine

    Medicine, 2025

    DOI 10.1097/md.0000000000041468 PMID 39928785 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  3. Machine Learning-Based Prognostic Modelling Using MRI Radiomic Data in Cervical Cancer Treated with Definitive Chemoradiotherapy and Brachytherapy

    Current Oncology, 2025

    DOI 10.3390/curroncol32110602 PMID 41294664 Open-access full textSource: ORCID

  4. Clinical factors predicting objective response to bevacizumab-based chemotherapies in advanced and recurrent epithelial ovarian cancer

    Minerva Obstetrics and Gynecology, 2024

    DOI 10.23736/s2724-606x.24.05540-4 PMID 38837188 Source: OpenAlex

  5. Efficacy of inthratecal therapy in breast cancer patients with Leptomeningeal Metastasis

    Eastern Journal Of Medicine, 2024

    DOI 10.5505/ejm.2024.42890 Open-access full textSource: OpenAlex

  6. Panel Reactive Antibody Responses Against Influenza Vaccination in Kidney Transplant Recipients

    Transplantation Proceedings, 2019

    DOI 10.1016/j.transproceed.2019.02.009 PMID 31101183 2 citations (OpenAlex) Source: OpenAlex

  7. Questions About Calculating the Effects of Albumin Therapy for Spontaneous Bacterial Peritonitis

    Clinical Gastroenterology and Hepatology, 2012

    DOI 10.1016/j.cgh.2012.03.028 PMID 22504001 Source: OpenAlex